Axcella Health Stock News

Healthcare > Biotechnology

Buy AXLA

*Your capital is at risk

$0.401

+0 (+0%)

At Close: Mar 28, 2024

3 Pharma Stocks to Dump Before the Damage Is Done

08:00am, Sunday, 08'th Oct 2023

Pharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defeats in which share prices decline precipitously.

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

11:28am, Wednesday, 20'th Sep 2023

The biotech sector never fails to offer up stocks full of massive issues at any given time. Developing novel therapeutic devices and pharmaceuticals is, after all, very expensive.

Are Medical Stocks Lagging Axcella Health (AXLA) This Year?

11:17am, Friday, 15'th Sep 2023

Here is how Axcella Health Inc. (AXLA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

Why Is Axcella Health (AXLA) Stock Down 24% Today?

09:01am, Friday, 15'th Sep 2023

Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split. According to Axcella Health, shares of AXLA stock are goi

Axcella Announces Reverse Stock Split Effective September 19, 2023

04:30pm, Thursday, 14'th Sep 2023

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using com

Why Is Axcella Health (AXLA) Stock Down 21% Today?

09:05am, Thursday, 31'st Aug 2023

Axcella Health (NASDAQ: AXLA ) stock is falling on Thursday following its announcement of a new Covid-19 treatment patent. However, it's not that this is bad news for the clinical-stage biotechnology

Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug

10:31am, Wednesday, 30'th Aug 2023

Axcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead candidate, AXA1125, which is currently under development to treat fatigue associated with Long Covid.

Why Is Axcella Health (AXLA) Stock Up 280% Today?

01:19pm, Tuesday, 29'th Aug 2023

A little-known penny stock is among the market's top movers today. Axcella Health (NASDAQ: AXLA ) stock surged by as much as 280% on news that it has been granted an important new patent.

Axcella Health stock rockets on long Covid patent win

09:28am, Tuesday, 29'th Aug 2023

Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a patent for its treatment for ‘long' Covid fatigue.

Axcella Granted Patent for Long COVID Fatigue Treatment

08:00am, Tuesday, 29'th Aug 2023

Why Is Axcella Health (AXLA) Stock Up 68% Today?

08:04am, Tuesday, 22'nd Aug 2023

Axcella Health (NASDAQ: AXLA ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company. There are no new press releases or filings with the Securitie

Axcella Reports Second Quarter Financial Results and Provides Business Update

07:30am, Thursday, 03'rd Aug 2023

Axcella Reports First Quarter Financial Results and Provides Business Update

04:30pm, Thursday, 04'th May 2023

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metab

Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023

08:00am, Monday, 17'th Apr 2023

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted endogenous

Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

08:00am, Thursday, 30'th Mar 2023

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by